However, the important role of Orai1 in mitigating muscle fatigue during repetitive stimulation (Michelucci et al., 2019; Fig. S6) may limit the therapeutic benefit of inhibiting Orai1 function in individuals with DMD. The gene discussed is ORAI1; the disease is Duchenne muscular dystrophy.